Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir.
Saved in:
| Title: | Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir. |
|---|---|
| Authors: | Singh RSP; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Toussi SS; Pfizer Worldwide Research, Development and Medical, Pearl River, New York, USA., Hackman F; Pfizer Worldwide Research, Development and Medical, Cambridge, UK., Chan PL; Pfizer Global Product Development, Sandwich, UK., Rao R; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Allen R; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Van Eyck L; Pfizer Clinical Research Unit, Brussels, Belgium., Pawlak S; Pfizer Clinical Research Unit, New Haven, Connecticut, USA., Kadar EP; Pfizer Worldwide Research, Development and Medical, Groton, Connecticut, USA., Clark F; Pfizer Worldwide Research, Development and Medical, Groton, Connecticut, USA., Shi H; Pfizer Global Product Development, Groton, Connecticut, USA., Anderson AS; Pfizer Worldwide Research, Development and Medical, Pearl River, New York, USA., Binks M; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Menon S; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Nucci G; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA., Bergman A; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Jul; Vol. 112 (1), pp. 101-111. Date of Electronic Publication: 2022 May 04. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.2603 |